FDA-Approved Drug Yields Promising Results for Itch Relief miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Federated Hermes Inc. lowered its position in Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) by 46.5% in the 2nd quarter, Holdings Channel reports. The fund owned 3,217 shares of the biopharmaceutical company’s stock after selling 2,792 shares during the quarter. Federated Hermes Inc.’s holdings in Cara Therapeutics were worth $29,000 as of its most recent […]
24.08.2022 - Presentation will highlight opportunity for oral difelikefalin to address a significant unmet need in the treatment of pruritus in patients with NPSTAMFORD, Conn., Aug. 24, 2022 (GLOBE NEWSWIRE) - Cara Therapeutics, Inc. (Nasdaq: CARA), a .
Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Notalgia Paresthetica -Study. | June 30, 2022